Another amazing year is in the books for me and CLSDF! What resonates most is the incredible people who I am honored to interact with on a daily basis. Sure there is the business of the business to take care of, but it is always important to recall that the intent of this community is [...]

• 283http://clsdf.com/2007/12/clsdf-2007-and-that%e2%80%99s-a-wrap/CLSDF+2007%3A+And+That%E2%80%99s+A+Wrap%212007-12-21+17%3A28%3A00admin

Many are reeling from today’s near 28% plunge in Array’s (NASDAQ: ARRY) stock price based upon the news of a failed Phase II for ARRY-886…ummm, is the street calling it failure…people please, hold on there for a moment! What exactly happened in the Mek inhibitor molecule study of this first in class novel therapy used [...]

• 282http://clsdf.com/2007/12/array-read-between-the-lines/Array%3A+Read+Between+the+Lines%212007-12-21+06%3A35%3A00admin